Morgan Stanley »

Rapport Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Rapport Therapeutics (RAPP) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Rapport Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Rapport Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rapport Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2025-06-30 $790k 70k 11.37
2024-12-31 $400k 23k 17.67
2024-09-30 $496k 24k 20.48